Get the Stockscreener App
1.29
4.44%
-0.06
Pulmatrix Inc stock is traded at $1.29, with a volume of 18,795.
It is down -4.44% in the last 24 hours and down -5.15% over the past month.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$1.35
Open:
$1.37
24h Volume:
18,795
Relative Volume:
0.40
Market Cap:
$4.71M
Revenue:
$3,000
Net Income/Loss:
$-5.16M
P/E Ratio:
-0.9128
EPS:
-1.4133
Net Cash Flow:
$-5.43M
1W Performance:
-4.09%
1M Performance:
-5.15%
6M Performance:
-73.83%
1Y Performance:
-80.77%
1-Day Range:
$1.25
$1.385
1-Week Range:
$1.25
$1.46
52-Week Range:
$1.16
$9.37
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
1.29 | 4.93M | 3,000 | -5.16M | -5.43M | -1.4133 |
VRTX
Vertex Pharmaceuticals Inc
|
429.09 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
748.32 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
792.47 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
307.67 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.17 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Eos-backed investor takes 9.99% Pulmatrix (PULM) stake ahead merger - Stock Titan
PULM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmatrix, Inc. announced that it has received $1 million in funding - marketscreener.com
Pulmatrix closes $1M preferred stock placement with Eos affiliate - Investing.com
Pulmatrix Closes $1M Series B Preferred Stock Investment at $2.20 per Share as Part of Planned Merger with Eos SENOLYTIX 1 - Minichart
Pulmatrix announces closing of preferred stock transaction as part of planned merger - marketscreener.com
Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger - TradingView
Pulmatrix closes $1M preferred stock placement with Eos affiliate By Investing.com - Investing.com Canada
Pulmatrix Raises $1M in Preferred Stock Financing - TipRanks
Pulmatrix closes $1M Series B preferred private placement tied to planned merger - TradingView
Pulmatrix (NASDAQ: PULM) closes $1M Series B preferred tied to Eos merger - Stock Titan
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PR Newswire
Pulmatrix (PULM) Stock: Why Working Capital (Trades Higher) 2026-04-20Social Flow Trades - Xã Châu Thành
PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders - The AI Journal
Momentum Shift: Is Pulmatrix Inc in a consolidation phase2026 Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan
Stock Recap: Will Pulmatrix Inc benefit from current market trends2026 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Gains Report: Will Pulmatrix Inc benefit from seasonality2026 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn
Is Pulmatrix (PULM) Stock Good for Beginners | Price at $1.26, Down 4.55%Earnings Breakout - Cổng thông tin điện tử Tỉnh Sơn La
Is Pulmatrix (PULM) Stock Good for Long Term | Price at $1.35, Up 3.05%Reward Analysis - Cổng thông tin điện tử tỉnh Lào Cai
PULM Stock Analysis: Pulmatrix Inc. Biotech At $1.31 Post Minor Daily Decline - Cổng thông tin điện tử tỉnh Tây Ninh
FOMO Trade: Will Pulmatrix Inc benefit from current market trendsQuarterly Trade Review & Consistent Income Trade Recommendations - baoquankhu1.vn
FRA:2PU PB Ratio: 1.34 — 15% Above Median - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce $19 Million Merger to Advance Mitochondrial Therapies - Global Legal Chronicle
Pulmatrix shares dive as privately-held pharma company chooses to merge with Gyre Therapeutics instead - MSN
Ideas Watch: Is Pulmatrix Inc in a consolidation phaseQuarterly Trade Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Pulmatrix and Eos SENOLYTIX Announce $19M Merger to Advance AI-Driven Mitochondrial Therapies for Sarcopenia and Aging-Related Diseases 1 - Minichart
Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq - tipranks.com
Pulmatrix to Merge With Eos SENOLYTIX; Raises $1M Preferred, Eos Secures Up to $18M - TradingView
Pulmatrix (PULM) plans reverse merger with Eos SENOLYTIX, legacy holders keep ~6% - Stock Titan
Haynes Boone Advises on Pulmatrix–Eos Merger and $19MM Financing - ABF Journal
Pulmatrix to acquire Eos SENOLYTIX in $19M anti-aging deal - Investing.com India
Pulmatrix and Eos SENOLYTIX Unite to Pioneer Anti-Aging Therapies Targeting Mitochondrial Health - Beijing Times
Deal Watch: Pulmatrix Finds New Merger Partner In Eos Senolytix - Citeline News & Insights
Eos SENOLYTIX, Inc. agreed to acquire Pulmatrix, Inc. in a reverse merger transaction. - MarketScreener
Aug Fed Impact: Is Pulmatrix Inc forming higher highs and higher lows2026 Market Mood & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Pulmatrix: Merger With Eos SENOLYTIX To Advance Mitochondrial Therapies - Pulse 2.0
Pulmatrix To Merge with Eos SENOLYTIX - citybiz
Pulmatrix (PULM) to Acquire Eos Senolytix in Strategic Merger - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PR Newswire
Pulmatrix, Inc. announced that it expects to receive $1 million in funding - marketscreener.com
Buyout Rumor: Can Pulmatrix Inc grow without dilution2026 Closing Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Aug Catalysts: What are the analyst revisions for Vroom IncIs Pulmatrix Inc stock a good investment in YEARTrade Exit Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Risk Off: What is the earnings history of Pulmatrix IncWeekly Stock Report & Weekly High Conviction Ideas - baoquankhu1.vn
Why Pulmatrix Inc. stock is a value investor pickJuly 2025 Price Swings & Daily Growth Stock Investment Tips - Naître et grandir
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits
Surprises Report: Will Pulmatrix Inc benefit from rising consumer demandShare Buyback & Capital Efficient Trade Techniques - baoquankhu1.vn
Pulmatrix, Inc. (PULM) Competitors - Meyka
Pulmatrix Pursues New Reverse Merger After Cullgen Termination - The Globe and Mail
Pulmatrix merger with Cullgen terminated by Chinese firm - Investing.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
2.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):